Holen Sie sich die Stockscreener-App
0.00
100.00%
-0.765
Schlusskurs vom Vortag:
$0.765
Offen:
$0
24-Stunden-Volumen:
0
Relative Volume:
0.00
Marktkapitalisierung:
$3.71M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
0.00
EPS:
-0.604
Netto-Cashflow:
-
1W Leistung:
-100.00%
1M Leistung:
-100.00%
6M Leistung:
-100.00%
1J Leistung:
-100.00%
1-Tages-Spanne:
$0.00
$0.00
1-Wochen-Bereich:
$0.00
$0.00
52-Wochen-Spanne:
$0.00
$3.59
Genetic Technologies Ltd Adr Stock (GENE) Company Profile
Firmenname
Genetic Technologies Ltd Adr
Sektor
Branche
Telefon
-
Adresse
-
Vergleichen Sie GENE mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
GENE
Genetic Technologies Ltd Adr
|
0.00 | 3.71M | 0 | 0 | 0 | 0.00 |
|
TMO
Thermo Fisher Scientific Inc
|
580.57 | 222.07B | 42.88B | 6.34B | 7.27B | 16.53 |
|
DHR
Danaher Corp
|
215.01 | 154.61B | 23.88B | 3.90B | 5.30B | 5.28 |
|
A
Agilent Technologies Inc
|
147.04 | 41.95B | 6.51B | 1.29B | 1.37B | 4.42 |
|
IDXX
Idexx Laboratories Inc
|
465.03 | 38.08B | 3.84B | 866.24M | 792.60M | 10.37 |
|
IQV
Iqvia Holdings Inc
|
200.04 | 36.31B | 15.32B | 1.41B | 1.96B | 7.62 |
Genetic Technologies Ltd Adr Aktie (GENE) Neueste Nachrichten
SOHM, Inc. Secures Key Patent for Revolutionary Gene Editing Technology - Sangri Today Spotlight
Genetic Technologies files regulatory report - Investing.com India
Genetic Technologies appoints voluntary administrators By Investing.com - Investing.com South Africa
Genetic Technologies appoints voluntary administrators - Investing.com India
10 Biggest Biotechnology Companies - Investopedia
Japan Plasmid DNA Manufacturing Market Size & Outlook, 2030 - Grand View Research
Middle East & Africa Plasmid DNA Manufacturing Market Size & Outlook, 2030 - Grand View Research
Genetic Technologies faces NASDAQ equity shortfall - Investing.com India
Genetic Technologies joins "CancerIQ" platform - Investing.com
Stocks of the Hour: DroneShield, Genetic Technologies, Cauldron Energy - ShareCafe
Genetic Technologies faces Nasdaq noncompliance issue - Investing.com
Genetic Technologies faces Nasdaq noncompliance issue By Investing.com - Investing.com UK
Genetic Technologies launches geneType on EasyDNA platform - Investing.com
Ascendis Pharma (ASND) Surges 8.7%: Is This an Indication of Further Gains? - Yahoo Finance
India Pancreatic Cancer Diagnostic Market Size & Outlook, 2030 - Grand View Research
India Plasmid DNA Manufacturing Market Size & Outlook, 2030 - Grand View Research
China Hereditary Testing Market Size & Outlook, 2023-2030 - Grand View Research
Anocca AB Licenses Gene Editing Technology from EmendoBio Inc. - Yahoo Finance
6 Best Genomics Stocks to Buy in 2024 - The Motley Fool
A pharmacogenetic study of perampanel: association between rare variants of glutamate receptor genes and outcomes - Frontiers
Genetic Technologies Limited Announces Ordinary Share Consolidation and ADS Ratio Change - Yahoo Finance
Check Up: How supramolecular technology is used in biotech, and why L’Oréal wants to get its hands on it - Stockhead
Check Up: Biotech is worth ‘US$4 trillion in 10 years’, and here’s where the smart money ... - Stockhead
Alexion, AstraZeneca Rare Disease, enters agreement with Pfizer to acquire a portfolio of preclinical rare disease gene therapies - AstraZeneca
Check Up: Almost half a billion US dollars raised to bring back mammoth, dodo, and Tassie tiger - Stockhead
Syncona to acquire Applied Genetic Technologies Corporation - BioPharma-Reporter.com
Le 1001 azioni che si sono schiantate sul mercato azionario USA - Scenari Economici
Start of demonstration experiment of algal breeding technology to solve climate change issues -Aiming to establish the world's first useful algae breeding technology by introducing genetic mutation through neutron irradiation- - NTT
Tech - GSK
Pharmacogenomics Market Size, Share & Growth Report 2032 - P&S Intelligence
Check up: 78 biotech companies rocked the boat this week but only one has real news - Stockhead
Genetic Technologies Ltd.ADR Shares Fall 0.8% Below Previous 52-Week LowMarket Mover - Nasdaq
MOU between MPUAT and Sona Genetics Pvt. Limited, Ahmedabad - Krishak Jagat English
The Daily Biotech Pulse: Novartis Funding For Gene Therapy Research, Priority Review For Amgen Cancer Drug, Pfizer-BioNTech Vaccine Supply Deal - Yahoo Finance
The Daily Biotech Pulse: DermTech Soars On Contract, Fluidigm Plunges On Earnings, Decision Day For Regeneron, Bioventus Debuts - Benzinga
The Daily Biotech Pulse: Pfizer's Eczema Drug Aces Latestage Study, Orphan Drug Designation For Dicerna, Dyadic's COVID-19 Connection - Yahoo Finance
6 ASX BioTechs Trading on the NASDAQ - TheBull.com.au
Why XOMA Corp. (Nasdaq: XOMA) Stock Jumped 24.4% in One Day - Money Morning
BioMarin is a global biotechnology company with eight marketed products that treat life-threatening conditions. - BioMarin Pharmaceutical Inc.
Former Genetic Technologies chief jailed for market manipulation; Merry Christmas ahead for property buyers at auctions: Midday Roundup - SmartCompany
Brazilian telcos higher on merger talk - MarketWatch
Pfizer: One of the world's premier biopharmaceutical companies - Pfizer
GTG lists on Nasdaq national market - Lab + Life Scientist
Finanzdaten der Genetic Technologies Ltd Adr-Aktie (GENE)
Es liegen keine Finanzdaten für Genetic Technologies Ltd Adr (GENE) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
5.26%
0.47%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):